Balyasny Asset Management’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-11,492
| Closed | -$25.3K | – | 2204 |
|
|
2025
Q1 | $25.3K | Buy |
+11,492
| New | +$25.3K | ﹤0.01% | 1942 |
|
|
2024
Q3 | – | Sell |
-26,868
| Closed | -$94K | – | 2128 |
|
|
2024
Q2 | $94K | Buy |
+26,868
| New | +$94K | ﹤0.01% | 1768 |
|
|
2023
Q1 | – | Sell |
-294,063
| Closed | -$735K | – | 2395 |
|
|
2022
Q4 | $735K | Buy |
294,063
+262,374
| +828% | +$656K | ﹤0.01% | 1347 |
|
|
2022
Q3 | $133K | Sell |
31,689
-471,996
| -94% | -$1.98M | ﹤0.01% | 1894 |
|
|
2022
Q2 | $1.41M | Buy |
+503,685
| New | +$1.41M | ﹤0.01% | 1282 |
|
|
2022
Q1 | – | Sell |
-602,613
| Closed | -$5.5M | – | 2276 |
|
|
2021
Q4 | $5.5M | Buy |
602,613
+121,841
| +25% | +$1.11M | 0.02% | 694 |
|
|
2021
Q3 | $5.14M | Buy |
480,772
+89,339
| +23% | +$955K | 0.02% | 666 |
|
|
2021
Q2 | $6.08M | Buy |
+391,433
| New | +$6.08M | 0.03% | 581 |
|
|
2019
Q2 | – | Sell |
-191,698
| Closed | -$4.69M | – | 1425 |
|
|
2019
Q1 | $4.69M | Buy |
191,698
+86,493
| +82% | +$2.11M | 0.03% | 514 |
|
|
2018
Q4 | $2.73M | Sell |
105,205
-210,249
| -67% | -$5.45M | 0.02% | 557 |
|
|
2018
Q3 | $9.98M | Buy |
+315,454
| New | +$9.98M | 0.05% | 404 |
|
|
2018
Q2 | – | Sell |
-1,632,240
| Closed | -$45.1M | – | 1727 |
|
|
2018
Q1 | $45.1M | Buy |
1,632,240
+2,359
| +0.1% | +$65.1K | 0.19% | 129 |
|
|
2017
Q4 | $29.5M | Buy |
1,629,881
+487,926
| +43% | +$8.83M | 0.09% | 269 |
|
|
2017
Q3 | $18.4M | Sell |
1,141,955
-79,448
| -7% | -$1.28M | 0.07% | 290 |
|
|
2017
Q2 | $16.9M | Buy |
1,221,403
+24,688
| +2% | +$342K | 0.07% | 325 |
|
|
2017
Q1 | $18M | Buy |
+1,196,715
| New | +$18M | 0.08% | 278 |
|